Breaking News Instant updates and real-time market news.

RXN

Rexnord

$23.41

0.54 (2.36%)

07:25
01/03/19
01/03
07:25
01/03/19
07:25

Rexnord price target lowered to $25 from $31 at Credit Suisse

Credit Suisse analyst John Walsh lowered his price target for Rexnord to $25 from $31 to reflect a 20bps reduction in global industrial production expectations, a 200bps reduction in energy capex driven by reduced E&P spending, and current FX rates. The analyst reiterates a Neutral rating on the shares.

  • 28

    Feb

RXN Rexnord
$23.41

0.54 (2.36%)

11/23/18
FBCO
11/23/18
DOWNGRADE
FBCO
Neutral
Rexnord assumed with a Neutral from Outperform at Credit Suisse
Credit Suisse analyst John Walsh assumed coverage of Rexnord with Neutral rating, down from the firm's prior Outperform rating. Walsh, who set a $31 price target on Rexnord shares, thinks recent portfolio changes away from mining and oil and gas and toward a consumer focus have better positioned the company, but he does not see a near-term catalyst for the shares, he tells investors.
10/02/18
GSCO
10/02/18
INITIATION
Target $31
GSCO
Neutral
Rexnord initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Joe Ritchie initiated Rexnord with a Neutral rating and a price target of $31 as part of his broader research note on SMID industrials that are "setting up for strong end to 2018". The analyst says the stock features a "balanced construction/general industrial mix", particularly as it relates to leverage to replacement demand in non residential construction. Ritchie expects organic growth of 5% in FY19 and 4% in FY20, but also believes that the shares are fully valued and improvement going forward will slow down.
02/15/18
LEHM
02/15/18
INITIATION
Target $30
LEHM
Equal Weight
Rexnord initiated with an Equal Weight at Barclays
Barclays analyst Julian Mitchell started Rexnord with an Equal Weight rating and $30 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
02/08/18
OPCO
02/08/18
UPGRADE
Target $33
OPCO
Outperform
Rexnord upgraded to Outperform following recent pullback at Oppenheimer
Oppenheimer analyst Jim Giannakouros upgraded Rexnord to Outperform from Perform with a $33 price target. The analyst likes Rexnord's prospects for growth acceleration and "enhanced" margin progression following its "upbeat" earnings call and guidance. He sees the shares continuing to appreciate over the intermediate term and recommends taking advantage of the recent pullback.

TODAY'S FREE FLY STORIES

AMSC

AMSC

$7.76

-0.04 (-0.51%)

08:03
11/19/19
11/19
08:03
11/19/19
08:03
Hot Stocks
AMSC announces $20M D-VAR system orders »

AMSC announced $20M of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KR

Kroger

$27.01

0.26 (0.97%)

08:03
11/19/19
11/19
08:03
11/19/19
08:03
Hot Stocks
Kroger announces partnership with Infarm »

The Kroger announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IKTSY

Intertek

$0.00

(0.00%)

08:03
11/19/19
11/19
08:03
11/19/19
08:03
Upgrade
Intertek rating change  »

Intertek upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOG

GasLog

$9.26

-0.36 (-3.74%)

08:03
11/19/19
11/19
08:03
11/19/19
08:03
Conference/Events
GasLog management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

PSNL

Personalis

$8.89

-0.85 (-8.73%)

, MKGAY

Merck KGaA

$0.00

(0.00%)

08:03
11/19/19
11/19
08:03
11/19/19
08:03
Hot Stocks
Personalis announces collaboration with Merck KGaA »

Personalis (PSNL)…

PSNL

Personalis

$8.89

-0.85 (-8.73%)

MKGAY

Merck KGaA

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

AGEN

Agenus

08:03
11/19/19
11/19
08:03
11/19/19
08:03
Initiation
Agenus initiated  »

Agenus resumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGEN

Agenus

$4.38

0.65 (17.43%)

08:03
11/19/19
11/19
08:03
11/19/19
08:03
Initiation
Agenus initiated  »

Agenus resumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CREE

Cree

$47.57

-1.17 (-2.40%)

, STM

STMicroelectronics

$24.25

0.05 (0.21%)

08:02
11/19/19
11/19
08:02
11/19/19
08:02
Hot Stocks
Cree, STMicroelectronics expand, extend SiC wafer supply agreement »

Cree, Inc. (CREE) and…

CREE

Cree

$47.57

-1.17 (-2.40%)

STM

STMicroelectronics

$24.25

0.05 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Dec

CNSP

CNS Pharmaceuticals

$4.25

-0.13 (-2.97%)

08:02
11/19/19
11/19
08:02
11/19/19
08:02
Hot Stocks
CNS completes agreement with HPI to obtain rights for Berubicin »

CNS Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHAT

Phathom Pharmaceuticals

$24.88

-1.12 (-4.31%)

08:00
11/19/19
11/19
08:00
11/19/19
08:00
Initiation
Phathom Pharmaceuticals initiated  »

Phathom Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTON

Peloton

$30.22

2.94 (10.78%)

08:00
11/19/19
11/19
08:00
11/19/19
08:00
Options
Peloton Interactive call buyer realizes 42% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

08:00
11/19/19
11/19
08:00
11/19/19
08:00
General news
U.S. chain store sales edged up 0.5% in the November 16 week »

U.S. chain store sales…

GDDY

GoDaddy

$68.29

0.195 (0.29%)

07:58
11/19/19
11/19
07:58
11/19/19
07:58
Conference/Events
GoDaddy management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 03

    Dec

  • 09

    Dec

ZEAL

Zealand Pharma

$36.13

2.7 (8.08%)

07:57
11/19/19
11/19
07:57
11/19/19
07:57
Downgrade
Zealand Pharma rating change  »

Zealand Pharma downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTR

Ventas

$58.35

0.1 (0.17%)

07:57
11/19/19
11/19
07:57
11/19/19
07:57
Upgrade
Ventas rating change  »

Ventas upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRPT

Freshpet

$54.47

-0.81 (-1.47%)

07:56
11/19/19
11/19
07:56
11/19/19
07:56
Conference/Events
Freshpet management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

HD

Home Depot

$238.98

1.64 (0.69%)

07:54
11/19/19
11/19
07:54
11/19/19
07:54
Recommendations
Home Depot analyst commentary  »

Home Depot selloff after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 11

    Dec

DAVA

Endava

$44.12

0.12 (0.27%)

07:53
11/19/19
11/19
07:53
11/19/19
07:53
Earnings
Endava raises FY20 adj. EPS view to GBP0.86-GBP0.89 from GBP0.85-GBP0.88 »

Cuts FY20 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 26

    Nov

EURN

Euronav NV

$10.81

-0.18 (-1.64%)

07:53
11/19/19
11/19
07:53
11/19/19
07:53
Syndicate
Euronav NV 3.75M share Secondary priced at $10.44 »

UBS acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAVA

Endava

$44.12

0.12 (0.27%)

07:51
11/19/19
11/19
07:51
11/19/19
07:51
Earnings
Endava sees Q2 adj. EPS GBP0.21-GBP0.22 »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 26

    Nov

FORM

FormFactor

$22.97

-0.24 (-1.03%)

07:51
11/19/19
11/19
07:51
11/19/19
07:51
Conference/Events
FormFactor management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

EFX

Equifax

$139.44

1 (0.72%)

07:50
11/19/19
11/19
07:50
11/19/19
07:50
Hot Stocks
Equifax extends relationship with NCTUE »

Equifax has extended its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAVA

Endava

$44.12

0.12 (0.27%)

07:49
11/19/19
11/19
07:49
11/19/19
07:49
Earnings
Endava reports Q1 adj. EPS GBP0.24 vs. GBP0.17 last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 26

    Nov

ANSS

Ansys

$238.67

3.63 (1.54%)

07:48
11/19/19
11/19
07:48
11/19/19
07:48
Recommendations
Ansys analyst commentary  »

Ansys price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 02

    Dec

  • 11

    Dec

HP

Helmerich & Payne

$38.84

-1.72 (-4.24%)

07:48
11/19/19
11/19
07:48
11/19/19
07:48
Downgrade
Helmerich & Payne rating change  »

Helmerich & Payne…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.